NCT03770312View on ClinicalTrials.gov

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >75 Years: the SCOPE-75 RCT Study

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

2,484

Participants

Timeline

Start Date

March 5, 2020

Primary Completion Date

January 16, 2026

Study Completion Date

January 16, 2026

Conditions

Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease

Interventions

DRUG

Low intensity statin

Use of low intensity statin for primary prevention of cardiovascular disease.

DRUG

Moderate intensity statin

Use of moderate intensity statin for primary prevention of cardiovascular disease.

Trial Locations (1)

03722

Division of Cardiology, Cardiovascular Center, Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT03770312 - Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >75 Years: the SCOPE-75 RCT Study | Biotech Hunter | Biotech Hunter